HomeCompareIBXXF vs PLD

IBXXF vs PLD: Dividend Comparison 2026

IBXXF yields 17857.14% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXXF wins by $17047106584171659264.00M in total portfolio value
10 years
IBXXF
IBXXF
● Live price
17857.14%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17047106584171659264.00M
Annual income
$16,861,361,028,467,424,000,000,000.00
Full IBXXF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — IBXXF vs PLD

📍 IBXXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXXFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXXF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXXF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXXF
Annual income on $10K today (after 15% tax)
$1,517,857.14/yr
After 10yr DRIP, annual income (after tax)
$14,332,156,874,197,310,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, IBXXF beats the other by $14,332,156,874,197,310,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXXF + PLD for your $10,000?

IBXXF: 50%PLD: 50%
100% PLD50/50100% IBXXF
Portfolio after 10yr
$8523553292085829632.00M
Annual income
$8,430,680,514,233,712,000,000,000.00/yr
Blended yield
98.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

IBXXF
No analyst data
Altman Z
-55.2
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXXF buys
0
PLD buys
0
No recent congressional trades found for IBXXF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXXFPLD
Forward yield17857.14%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$17047106584171659264.00M$5.91M
Annual income after 10y$16,861,361,028,467,424,000,000,000.00$4,750,725.19
Total dividends collected$17034838237245739008.00M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IBXXF vs PLD ($10,000, DRIP)

YearIBXXF PortfolioIBXXF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$1,796,414$1,785,714.29$11,241$540.96+$1.79MIBXXF
2$301,724,280$299,802,117.11$13,019$991.13+$301.71MIBXXF
3$47,383,143,508$47,060,298,527.98$15,801$1,870.97+$47383.13MIBXXF
4$6,957,621,293,196$6,906,921,329,642.40$20,609$3,701.21+$6957621.27MIBXXF
5$955,290,364,037,133$947,845,709,253,412.80$29,919$7,867.97+$955290364.01MIBXXF
6$122,648,736,931,019,340$121,626,576,241,499,600.00$50,631$18,617.74+$122648736930.97MIBXXF
7$14,725,168,454,748,666,000$14,593,934,306,232,474,000.00$105,528$51,352.20+$14725168454748.56MIBXXF
8$1,653,272,868,532,626,000,000$1,637,516,938,286,045,300,000.00$287,364$174,449.42+$1653272868532625.75MIBXXF
9$173,593,977,293,677,440,000,000$171,824,975,324,347,530,000,000.00$1,081,760$774,280.77+$173593977293677440.00MIBXXF
10$17,047,106,584,171,660,000,000,000$16,861,361,028,467,424,000,000,000.00$5,908,209$4,750,725.19+$17047106584171659264.00MIBXXF

IBXXF vs PLD: Complete Analysis 2026

IBXXFStock

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.

Full IBXXF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this IBXXF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXXF vs SCHDIBXXF vs JEPIIBXXF vs OIBXXF vs KOIBXXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.